Translate

Friday, November 6, 2020

thumbnail

SELB Selecta Biosciences Inc gains 17% Nov 6, 2020

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.http://www.priceseries.com/trade/SELB-Selecta-Biosciences-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020102120201106.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive